Lara Sullivan, Pyxis Oncology CEO, joins Yahoo Finance to discuss the biotech company going public and its oncology treatments for patients with difficult-to-treat cancer. JARED BLIKRE: Well, an IPO ...

Overview: Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics for the treatment of solid tumors, with a market cap of $220.78 million. Operations: The company generates ...

Pyxis Oncology (NASDAQ:PYXS), a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment, has been garnering attention from investors and ...

Discover who owns Pyxis Tankers Inc. Access the ownership overview, view the top Pyxis Tankers Inc shareholders, institutional holders, and leading mutual fund investors. Understand the key ...